Research from WBB Securities provides investment professionals with up-to-date, in-depth, accurate and insightful reporting of companies that specialize in biotechnology, medical devices and healthcare. Our goal is to provide independent, straight-forward and up-to-date research so you can make educated decisions about your investments.
Our analysts and advisers are uniquely qualified to provide both technical and financial insight to the companies we cover. Four of our contributors are physicians and one is a PhD in organic chemistry.
WBB follows a select group of companies. They are chosen based on unique technology, a critical medical need, quality of leadership, financial resources and other criteria. WBB-followed companies usually fall into the following categories:
- Undervalued companies with unusually promising technology.
- Companies on the verge of a scientific or business breakthrough.
- Overvalued companies that need to be watched closely.
Our research is available through the Thomson First Call Service or to qualified readers on request. For additional information about WBB Securities research services, please fill out the form below. A member of our research team will contact you as soon as possible.
For more information, please contact us by clicking here. Or call Stephen Brozak at (908) 518-7610.